Home › Sickle Cell Disease › New York › New York City
Pag-aaral pangklinika para sa Sickle Cell Disease sa New York City, NY
Isang pag-aaral para sa Sickle Cell Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New York City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Nagre-recruitPhase 1
- Mount Sinai Hospital, New York
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Nagre-recruitPhase 3
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Nagre-recruitPhase 2/3
- Icahn School of Medicine at Mount Sinai, New York
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Nagre-recruitObservasyonal na pag-aaral
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Nagre-recruitPhase 2
- Mount Sinai Medical Center, New York
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
Nagre-recruitPhase 1/2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering, New York
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Nagre-recruitPhase 1
- Columbia University Irving Medical Center, New York
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Nagre-recruitObservasyonal na pag-aaral
- Columbia Presbytarian (NT-DMT), New York
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Nagre-recruitPhase 3
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Nagre-recruitPhase 2
- Columbia University, New York
A Long-term Follow-up Study in Patients Who Received BEAM-101
Nagre-recruitObservasyonal na pag-aaral
- Columbia University Irving Medical Center, New York
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Nagre-recruit
- Weil Cornell Medical College, New York
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
Nagre-recruitPhase 2
- Mount Sinai Hospital, New York
Pag-aaral para sa Sickle Cell Disease sa ibang lungsod
- Atlanta, GA22 pag-aaral
- Washington, DC20 pag-aaral
- Chicago, IL18 pag-aaral
- Memphis, TN18 pag-aaral
- Philadelphia, PA15 pag-aaral
- Birmingham, AL14 pag-aaral
- St. Louis, MO12 pag-aaral
- Boston, MA10 pag-aaral
- Durham, NC10 pag-aaral
- Houston, TX10 pag-aaral
- Cincinnati, OH10 pag-aaral
- Greenville, NC9 pag-aaral
Iba pang pag-aaral sa New York City
- Kanser sa Suso136 pag-aaral
- Non-Small Cell Lung Cancer121 pag-aaral
- Kanser (lahat ng uri)109 pag-aaral
- Kanser sa Prostate103 pag-aaral
- Metastatic Cancer93 pag-aaral
- Colorectal Cancer78 pag-aaral
- Kanser sa Ovary69 pag-aaral
- Kanser sa Baga60 pag-aaral
- Multiple Myeloma60 pag-aaral
- Kanser sa Pancreas60 pag-aaral
- Kanser ng Endometrium52 pag-aaral
- Acute Myeloid Leukemia51 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.